Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Finished Drug Prices
NA
1. 3-formylamino-7-methylsulfonylamino-6-phenoxy-4h-1-benzopyran-4-one
2. T 614
3. T-614
1. 123663-49-0
2. N-(7-(methylsulfonamido)-4-oxo-6-phenoxy-4h-chromen-3-yl)formamide
3. Careram
4. Kolbet
5. T-614
6. Iguratimod [inn]
7. Iremod
8. 4ihy34y2nv
9. 3-formylamino-7-methylsulfonylamino-6-phenoxy-4h-1-benzopyran-4-one
10. Ncgc00181783-02
11. T614
12. N-[7-(methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide
13. N-[7-methanesulfonamido-4-oxo-6-(phenoxy)chromen-3-yl]formamide
14. N-(7-((methylsulfonyl)amino)-4-oxo-6-phenoxy-4h-1-benzopyran-3-yl)formamide
15. Unii-4ihy34y2nv
16. Colvet
17. T 614
18. Iguratimod- Bio-x
19. Iguratimod [mi]
20. Iguratimod (jan/inn)
21. Iguratimod [jan]
22. Dsstox_cid_28897
23. Dsstox_rid_83165
24. Iguratimod [who-dd]
25. Dsstox_gsid_48971
26. Schembl26326
27. Gtpl9736
28. Chembl2107455
29. Dtxsid0048971
30. Iguratimod, >=98% (hplc)
31. Chebi:31689
32. Bcp04206
33. Tox21_113422
34. Bdbm50458537
35. Mfcd00882374
36. S5648
37. Akos015888743
38. Zinc100018451
39. Ccg-268349
40. Cs-0617
41. Db12233
42. Sb16814
43. Ncgc00181783-01
44. Ncgc00181783-03
45. As-12959
46. Bi164569
47. Hy-17009
48. A3484
49. Cas-123663-49-0
50. Ft-0654508
51. I0945
52. C71931
53. D01146
54. 663i490
55. A805134
56. Sr-01000945251
57. J-521483
58. Sr-01000945251-1
59. Q13575264
60. N-(3-formamido-4-oxo-6-phenoxy-4h-chromen-7-yl)methanesulfonamide
61. N-[7-(methanesulfonamido)-4-oxo-6-phenoxy-4h-chromen-3-yl]formamide
62. N-[7-(methanesulfonamido)-4-oxo-6-phenoxy-chromen-3-yl]formamide;iguratimod
Molecular Weight | 374.4 g/mol |
---|---|
Molecular Formula | C17H14N2O6S |
XLogP3 | 1.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 374.05725734 g/mol |
Monoisotopic Mass | 374.05725734 g/mol |
Topological Polar Surface Area | 119 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 665 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
Registration Number : 305MF10057
Registrant's Address : No. 9 Hantai North Road, Qinghe District, Huai\'an City, Jiangsu Province, P. R. China
Initial Date of Registration : 2023-05-10
Latest Date of Registration : --
Registration Number : 302MF10127
Registrant's Address : No. 2, Yaogu 3rd Road, Pharma Valley, Xiuying District, Haikou City, Hainan Province, 570311, China
Initial Date of Registration : 2020-10-14
Latest Date of Registration : --
Registration Number : 302MF10085
Registrant's Address : No. 9 Hantai North Road, Qinghe District, Huai\'an City, Jiangsu Province, P. R. China
Initial Date of Registration : 2020-07-22
Latest Date of Registration : --
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?